TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the American ...
Roche has said its oral BTK inhibitor fenebrutinib could become the first drug in the class to be approved for multiple ...
A new method replicated the findings of a previous clinical trial of Tecfidera in people with relapsing-remitting MS, a study ...
A new study published in the Journal of Neurology1 detailed the development of 2 machine learning–based tools that were able ...
Real-world use of an MS blood test shows how it helps monitor disease activity and guide treatment decisions in U.S. patients ...
Panelists discuss how the evaluation process must evolve to accommodate therapies that show benefits in slowing atrophy and motor decline over 1 to 2 years, emphasizing the need for early coverage ...
In the fast-paced ecosystem of Silicon Valley, "data" isn’t just a buzzword—it’s the currency of innovation. But realizing you need a data-focused master’s degree is only the first step. The harder ...
What Can You Do With an MS in Economics and Data Science? With an MS in Economics and Data Science, you can choose from a variety of industries and roles with high-growth potential. $108,020: Data ...
As MS NOW comes into full view next week, it’ll do so with its own weather reports. The cable network has struck a partnership with AccuWeather for access to its weather forecasts, data and crew of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results